Cell adhesion molecules and plasminogen activator inhibitor type-1 (PAI-1) in patients with rheumatoid arthritis: influence of metabolic syndrome
Version 2 2024-06-13, 16:56
Version 1 2023-10-23, 02:39
journal contribution
posted on 2024-06-13, 16:56 authored by MC de Sá, ANC Simão, FA de Medeiros, TMV Iriyoda, NT Costa, DF Alfieri, T Flauzino, BA Sekiguchi, MAB Lozovoy, EMV Reiche, M Maes, I DichiCell adhesion molecules and plasminogen activator inhibitor type-1 (PAI-1) in patients with rheumatoid arthritis: influence of metabolic syndrome
History
Journal
Clinical and Experimental MedicineVolume
18Pagination
495-504Location
Berlin, GermanyPublisher DOI
ISSN
1591-8890eISSN
1591-9528Language
EnglishPublication classification
C1 Refereed article in a scholarly journalIssue
4Publisher
SpringerUsage metrics
Categories
No categories selectedKeywords
cell adhesion moleculesmetabolic syndromeplasminogen activator inhibitor type-1rheumatoid arthritistumor necrosis factor-αCell adhesion moleculesMetabolic syndromePlasminogen activator inhibitor type-1Rheumatoid arthritisTumor necrosis factor-αAdultAgedArthritis, RheumatoidBiomarkersBlood SedimentationBody Mass IndexC-Reactive ProteinCase-Control StudiesCell Adhesion MoleculesComorbidityFemaleHumansLogistic ModelsMaleMetabolic SyndromeMiddle AgedPlasminogen Activator Inhibitor 1Platelet Endothelial Cell Adhesion Molecule-1Sensitivity and SpecificityTumor Necrosis Factor-alphaVascular Cell Adhesion Molecule-1
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC